Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Biogen Inc.
  6. Company
    BIIB   US09062X1037

BIOGEN INC.

(BIIB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Biogen Inc.
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Number of employees : 9 100 people.
Sales per Business
20192020Delta
Product11 379.8089.5%10 692.2086.5% -6.04%
Anti-CD20 Therapeutic Programs2 290.4018%1 977.8016% -13.65%
Other707.705.6%774.606.3% +9.45%
USD in Million
Sales per region
20192020Delta
United States9 511.5074.8%8 531.1069% -10.31%
Europe3 804.4029.9%3 664.6029.7% -3.67%
Asia432.503.4%629.605.1% +45.57%
Other629.505%619.305% -1.62%
USD in Million
Managers
Name Title Age Since
Michel Vounatsos Chief Executive Officer & Director 58 2017
Michael McDonnell Chief Financial Officer & Executive Vice President 56 2020
Alfred Sandrock Executive Vice President-Research & Development 62 2020
Mark Hernon Chief Information Officer & Senior Vice President - 2017
Alphonse Galdes EVP-Pharmaceutical Operations & Technology 67 2019
Mahalakshmi Radhakrishnan Chief Medical Officer & Group Senior VP - 2020
Nancy L. Leaming Independent Director 72 2008
Stelios Papadopoulos Chairman 71 2014
Brian S. Posner Independent Director 58 2008
Alexander Denner Independent Director 50 2009
Members of the board
Name Title Age Since
Stelios Papadopoulos Chairman 71 2014
Nancy L. Leaming Independent Director 72 2008
Brian S. Posner Independent Director 58 2008
Alexander Denner Independent Director 50 2009
Richard Charles Mulligan, Dr. Independent Director 65 2009
Caroline D. Dorsa Independent Director 60 2010
Eric K. Rowinsky, Dr. Independent Director 63 2011
Stephen A. Sherwin, Dr. Independent Director 71 2010
Michel Vounatsos Chief Executive Officer & Director 58 2017
William A. Hawkins Independent Director 66 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 174,354,750 148,022,709 84.9% 23,800,000 13.7% 84.9%
Shareholders
NameEquities%
PRIMECAP Management Co. 16,458,506 11.0%
The Vanguard Group, Inc. 11,129,102 7.47%
Capital Research & Management Co. 10,955,000 7.35%
SSgA Funds Management, Inc. 6,680,040 4.48%
Wellington Management Co. LLP 5,601,861 3.76%
Capital Research & Management Co. (Global Investors) 5,456,600 3.66%
JPMorgan Investment Management, Inc. 4,227,510 2.84%
ClearBridge Investments LLC 3,565,112 2.39%
BlackRock Fund Advisors 3,278,390 2.20%
Icahn Associates Holding LLC 3,215,051 2.16%
Holdings
NameEquities%Valuation
DENALI THERAPEUTICS INC. (DNLI) 13,310,243 10.9% 708,104,928 USD
SAGE THERAPEUTICS, INC. (SAGE) 6,241,473 10.6% 288,418,467 USD
SANGAMO THERAPEUTICS, INC. (SGMO) 24,420,157 16.8% 242,003,756 USD
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 100, S&P 500
Stock Exchange Codes
- Bloomberg Code :  BIIB:US
- Reuters Code :  BIIB.O
- Datastream Code :  
Company contact information
Biogen Inc.
225 Street Binney
MA 02142 Cambridge, Massachusetts

Phone : +1 617 679-2000
Fax :
web site : https://www.biogen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Biogen Inc.